

Nektar Therapeutics (India) Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 29.39 Cr
- Company Age 19 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 22.60%
- Profit Growth -364.93%
- Ebitda 10.67%
- Net Worth -16.12%
- Total Assets 3.67%
About Nektar Therapeutics (India)
Nektar Therapeutics (India) Private Limited (NTIPL) is a leading Private Limited Foreign Company Incorporated In India incorporated in India on 16 May 2005 and has a history of 19 years and 11 months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 29.39 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Nektar Therapeutics (India) Private Limited India is Phaneendra Modali as COMPANY SECRETARY. Uday Yemmanuru, Mark Wilson, and Robert Bacci serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2005FTC046253
- Company No.
046253
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
16 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Nektar Therapeutics (India) Private Limited offer?
Nektar Therapeutics (India) Private Limited offers a wide range of products and services, including .
Who are the key members and board of directors at Nektar Therapeutics (India)?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Phaneendra Modali | Company Secretary | 16-Jul-2018 | Current |
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Uday Yemmanuru ![]() | Director | 25-Mar-2024 | Current |
Mark Wilson ![]() | Director | 19-Mar-2019 | Current |
Robert Bacci | Director | 18-Jun-2024 | Current |
Financial Performance of Nektar Therapeutics (India).
Nektar Therapeutics (India) Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.6% increase. The company also saw a substantial fall in profitability, with a 364.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.12%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Nektar Therapeutics (India)?
In 2021, Nektar Therapeutics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Related Corporates (Common Directorship)
- Ntt India Digital Private Limited
Uday Yemmanuru is a mutual person
- Kvk-Eci Hydro Energy Private Limited
Uday Yemmanuru is a mutual person
- Mason Ready Mix Private Limited
Uday Yemmanuru is a mutual person
- Kvk Par Power Private Limited
Uday Yemmanuru is a mutual person
- Kvk Dardu Hydro Energy Private Limited
Uday Yemmanuru is a mutual person
- Worxmart Consulting Private Limited
Uday Yemmanuru is a mutual person
Charges (Loans)

There are no open charges registered against the company as per our records.
How Many Employees Work at Nektar Therapeutics (India)?
Nektar Therapeutics (India) has a workforce of 3 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Nektar Therapeutics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nektar Therapeutics (India)'s trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nektar Therapeutics (India)
Recent activity within the organization
- Annual General Meeting
Nektar Therapeutics (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Director Appointment
Robert Michael Bacci was appointed as a Director was appointed as a Director on 18 Jun 2024 & has been associated with this company since 10 months 25 days .
- Balance Sheet
Nektar Therapeutics (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Uday Chandra Yemmanuru was appointed as a Director was appointed as a Director on 25 Mar 2024 & has been associated with this company since 1 year 1 month .
- Director Appointment
Mark Andrew Wilson was appointed as a Director was appointed as a Director on 19 Mar 2019 & has been associated with this company since 6 years 1 month .
- Director Appointment
Phaneendra Modali was appointed as a Company Secretary was appointed as a Company Secretary on 16 Jul 2018 & has been associated with this company since 6 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Nektar Therapeutics (India) Private Limited?
Nektar Therapeutics (India) Private Limited was incorporated on 16 May 2005.
What is authorized share capital and paid-up capital of Nektar Therapeutics (India) Private Limited?
The authorized share capital of Nektar Therapeutics (India) Private Limited is ₹ 30.00 Cr and paid-up capital is ₹ 29.39 Cr.
Who are the current board members & directors of Nektar Therapeutics (India) Private Limited?
Currently 4 directors are associated with Nektar Therapeutics (India) Private Limited.
- Uday Chandra Yemmanuru
- Mark Andrew Wilson
- Robert Michael Bacci
- Phaneendra Modali
What is the registered address of Nektar Therapeutics (India) Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nektar Therapeutics (India) Private Limited is Plot No. 105/1, P T Colony Tirumalgherry India, Tirumalagiri, Telangana, 500015.
What is the corporate identification number (CIN) and company number of Nektar Therapeutics (India) Private Limited?
The corporate identification number (CIN) of Nektar Therapeutics (India) Private Limited is U24239TG2005FTC046253 and the company number is 046253 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nektar Therapeutics (India) Private Limited?
The Official website of Nektar Therapeutics (India) Private Limited is https://www.nektar.com
What has been the recent revenue trend for Nektar Therapeutics (India) Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Nektar Therapeutics (India) Private Limited has risen by 22.60%.
How many employees does Nektar Therapeutics (India) Private Limited currently have?
As Per 2022 financial reports, 3 employees are currently employed by Nektar Therapeutics (India) Private Limited.
What change has been observed in the net worth of Nektar Therapeutics (India) Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Nektar Therapeutics (India) Private Limited has experienced an downturn of -16.12%.
When was the last Balance Sheet of Nektar Therapeutics (India) Private Limited filed with the ROC?
The most recent Balance Sheet for Nektar Therapeutics (India) Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
- Ramesh PanchagnulaManaging Director
- Jillian ThomsenDirector
DJ
David JohnstonDirectorSD
Sarma DudduManaging DirectorJN
John NicholsonDirectorRN
Rangachari NarasimhanManaging DirectorVV
Venkata VadlamudiWholetime DirectorSD
Stephen DobersteinDirector
Similar Companies Based on Pharma Contract R&D
- Watson Pharma Private Limited Mumbai, Maharashtra, India
- Fortrea Development India Private Limited Bangaluru, Karnataka, India
- Jubilant Biosys Limited Gautam Buddha Nagar, Uttar Pradesh, India
- Aragen Life Sciences Limited Rangareddy, Telangana, India
- Amneal Pharmaceuticals Private Limited Ahmedabad, Gujarat, India
- Medreich Limited Bangaluru, Karnataka, India
- Aether Industries Limited Surat, Gujarat, India